Free Trial
OTCMKTS:ELVAF

Evolva (ELVAF) Stock Price, News & Analysis

Evolva logo
C$2.15 0.00 (0.00%)
As of 11/2/2026

About Evolva Stock (OTCMKTS:ELVAF)

Advanced

Key Stats

Today's Range
C$2.15
▼
C$2.15
50-Day Range
C$2.15
▼
C$2.15
52-Week Range
C$1.10
▼
C$2.15
Volume
N/A
Average Volume
587 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Evolva AG is a Swiss biotechnology company that historically developed and commercialized specialty ingredients through precision fermentation and other biosynthetic technologies. Its platform was designed to produce complex molecules more efficiently and sustainably than conventional extraction or chemical synthesis methods.

The company’s product portfolio included Veri-te resveratrol, a fermented ingredient used in nutritional supplements and functional foods; Nootkatone, a citrus-derived flavor and fragrance ingredient; and EverSweet, a steviol glycoside sweetener developed in partnership with Cargill. Evolva also worked on additional natural flavors, fragrances, health ingredients and food-related compounds.

Based in Reinach, Switzerland, Evolva served international food, beverage, nutrition, cosmetics and fragrance markets through commercial partnerships and ingredient customers. In its later years, the company underwent strategic and ownership changes, including the sale of its business to Lallemand. Evolva’s operations and corporate status may therefore differ from its historical profile.

AI Generated. May Contain Errors.

Receive ELVAF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Evolva and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ELVAF Stock News Headlines

Why Gerardo Del Real says wait before buying uranium stocks
Gerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he says has never existed before. In a similar setup in the past, select investors saw $1,000 turn into over $1 million within a few years. Del Real just released a full video breakdown of what is driving this move and how to prepare.tc pixel
See More Headlines

ELVAF Stock Analysis - Frequently Asked Questions

Evolva's stock was trading at C$1.10 at the start of the year. Since then, ELVAF stock has increased by 95.5% and is now trading at C$2.15.

Shares of ELVAF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
OTCMKTS:ELVAF
CIK
N/A
Fax
N/A
Employees
49
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (OTCMKTS:ELVAF) was last updated on 11/2/2026 by MarketBeat.com Staff.
From Our Partners